Elbit (ESLT) Surges 5.9%: Is This an Indication of Further Gains?
Elbit (ESLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...
Elbit Systems (ESLT) shares ended the last trading session 5.9% higher at $157.25. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1% gain over the past four weeks.
The latest uptick in Elbit Systems’ share performance can be attributed to the company’s announcement of a project to establish power generation and energy storage units at several of its facilities in Israel. In addition, the company will build a 3-megawatt energy generation plant powered by natural gas, an energy storage facility and a management system that will synchronize (on a daily basis) the production activity using various technologies. Considering the growth opportunities of the clean energy market, such an announcement must have boosted confidence of Elbit Systems’ investors and was reflected in the share price appreciation.
This maker of defense electronics is expected to post quarterly earnings of $1.85 per share in its upcoming report, which represents a year-over-year change of +12.8%. Revenues are expected to be $1.27 billion, up 11.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Elbit, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ESLT going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Elbit Systems Ltd. (ESLT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research